{"url":"https://lda.senate.gov/api/v1/filings/6b4281a2-36bf-438a-aee3-be97f95071d2/","filing_uuid":"6b4281a2-36bf-438a-aee3-be97f95071d2","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2025,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/6b4281a2-36bf-438a-aee3-be97f95071d2/print/","filing_document_content_type":"text/html","income":"10000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"William Moschella, Attorney at Law","dt_posted":"2025-10-17T12:04:57-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"600 Massachusetts Ave, NW","registrant_address_2":"Suite 400","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":7257,"url":"https://lda.senate.gov/api/v1/registrants/7257/","house_registrant_id":31842,"name":"BROWNSTEIN HYATT FARBER SCHRECK, LLP","description":"Law firm","address_1":"600 Massachusetts Ave, NW","address_2":"Suite 400","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"QUINN MCKAY","contact_telephone":"+1 202-872-5292","dt_updated":"2026-07-30T12:03:37.302760-04:00"},"client":{"id":69030,"url":"https://lda.senate.gov/api/v1/clients/69030/","client_id":69030,"name":"PIERRE FABRE PHARMACEUTICALS INC.","general_description":"Pharmaceutical manufacturer","client_government_entity":null,"client_self_select":false,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"CO","ppb_state_display":"Colorado","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-09-16"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Issues related to drug development, rare disease innovations, and issues impacting the pharmaceutical industry.","foreign_entity_issues":"Pierre Fabre SA and Pierre Fabre Foundation have an interest in drug development.","lobbyists":[{"lobbyist":{"id":61089,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"PFISTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":103206,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"STEINMETZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151303,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":null,"last_name":"HOLLAND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142877,"prefix":null,"prefix_display":null,"first_name":"GREGORY","nickname":null,"middle_name":null,"last_name":"SUNSTRUM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143000,"prefix":null,"prefix_display":null,"first_name":"DEEMA","nickname":null,"middle_name":null,"last_name":"TARAZI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}